SKUNF (Seikagaku) Accounts Payable: $6.6 Mil (As of Mar. 2026)


SKUNF Seikagaku Corp SKUNF
72 GF Score
Price $4.44
GF Value $17.00
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Seikagaku Accounts Payable?

Seikagaku SKUNF +0.91% 72 Accounts Payable is $6.6 Mil as of Mar. 2026. GuruFocus rates SKUNF with a GF Score™ of 72/100 and a GF Value™ of $17.00 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Seikagaku's Accounts Payable for the quarter that ended in Mar. 2026 was $6.6 Mil.

Seikagaku's quarterly Accounts Payable declined from Sep. 2025 ($8.1 Mil) to Dec. 2025 ($7.8 Mil) and declined from Dec. 2025 ($7.8 Mil) to Mar. 2026 ($6.6 Mil).

Seikagaku's annual Accounts Payable declined from Mar. 2024 ($11.0 Mil) to Mar. 2025 ($6.6 Mil) and declined from Mar. 2025 ($6.6 Mil) to Mar. 2026 ($6.6 Mil).

Seikagaku Accounts Payable Historical Data

* Premium members only.

The historical data trend for Seikagaku's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seikagaku Accounts Payable Chart

Seikagaku Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.74 6.58 11.03 6.65 6.59

Seikagaku Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.65 5.27 8.12 7.75 6.59
SKUNF
72GF Score
Seikagaku Corp SKUNF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seikagaku Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $6.6 Mil mean?
Seikagaku (SKUNF) has a Accounts Payable of $6.6 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Seikagaku and its competitors.
Is Seikagaku's Accounts Payable too high?
Seikagaku's current Accounts Payable is $6.6 Mil. Overall, Seikagaku has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Seikagaku's Accounts Payable compare to ABT and SYK?
Seikagaku's Accounts Payable of $6.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Seikagaku and its competitors. Seikagaku's current Accounts Payable is $6.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seikagaku stock overvalued right now?
Based on GuruFocus' analysis, Seikagaku (SKUNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.00, compared to a current price of $4.44 — trading 73.9% below its estimated fair value. The current Accounts Payable is $6.6 Mil. Seikagaku's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Seikagaku (SKUNF), the current Accounts Payable is $6.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Seikagaku (SKUNF) Overvalued in 2026?

Based on GuruFocus' analysis, Seikagaku stock appears to be undervalued. The current stock price of $4.44 is trading 73.9% below its estimated GF Value™ of $17.00. GuruFocus considers Seikagaku to be Significantly Undervalued.

Key valuation signals for SKUNF:

  • Accounts Payable: $6.6 Mil
  • GF Value™: $17.00 vs. price of $4.44 (73.9% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the SKUNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Seikagaku Business Description

Other Exchanges 4548:Japan
Address Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005
Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.
72GF Score

Get the complete analysis for SKUNF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.44
Price
$17.00
GF Value